Elevated C-reactive protein levels predict worsening prognosis in Chinese patients with first-onset stroke

Frontiers of Medicine in China

Volumn 3, Issue 1, 2009, Pages 30-35

  Yan, Jiangtao ^a   Hui, Rutai ^b   Wang, Daowen ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b FUWAI HOSPITAL   (China)

Author keywords

C reactive protein; Inflammation; Stroke

Indexed keywords

EID: 63349085433     PISSN: 16737342     EISSN: 16737458     Source Type: Journal    
DOI: 10.1007/s11684-009-0005-x     Document Type: Article

References (31)

1. Libby P. Inflammation in atherosclerosis. Nature, 2002, 420(6917): 868-874
2. Blake G J, Ridker P M. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med, 2002, 252(2): 283-294
3. Engstrom G, Hedblad B, Stavenow L, Tyden P, Lind P, Janzon L, Lindgarde F. Fatality of future coronary events is related to inflammation-sensitive plasma proteins: A population-based prospective cohort study. Circulation, 2004, 110(1): 27-31
4. Ridker P M, Hennekens C H, Buring J E, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med, 2000, 342(12): 836-843
5. Danesh J, Wheeler J G, Hirschfield G M, Eda S, Eiriksdottir G, Rumley A, Lowe G D O, Pepys M B, Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med, 2004, 350(14): 1387-1397
6. Koenig W, Sund M, Frohlich M, Fischer H G, Lowel H, Doring A, Hutchinson W L, Pepys M B. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the monica (monitoring trends and determinants in cardiovascular disease) augsburg cohort study, 1984 to 1992. Circulation, 1999, 99(2): 237-242
7. Ridker P M, Cushman M, Stampfer M J, Tracy R P, Hennekens C H. Plasma concentration of c-reactive protein and risk of developing peripheral vascular disease. Circulation, 1998, 97(5): 425-428
8. Rost N S, Wolf P A, Kase C S, Kelly-Hayes M, Silbershatz H, Massaro J M, D'Agostino R B, Franzblau C, Wilson P W. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: The Framingham study. Stroke, 2001, 32(11): 2575-2579
9. Thompson S G, Kienast J, Pyke S D, Haverkate F, van de Loo J C. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med, 1995, 332(10): 635-641
10. Haverkate F T S, Pyke S D, Gallimore J R, Pepys M B. Production of c-reactive protein and risk of coronary events in stable and unstable angina. European concerted action on thrombosis and disabilities angina pectoris study group. Lancet, 1997, 349(9050): 462-466
11. Liuzzo G, Biasucci L M, Gallimore J R, Grillo R L, Rebuzzi A G, Pepys M B, Maseri A. The prognostic value of c-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med, 1994, 331(7): 417-424
12. Hansson G K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med, 2005, 352(16): 1685-1695
13. Ridker P M, Cushman M, Stampfer M J, Tracy R P, Hennekens C H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med, 1997, 336(14): 973-979
14. Mega J L, Morrow D A, Cannon C P, Murphy S, Cairns R, Ridker P M, Braunwald E. Cholesterol, c-reactive protein, and cerebrovascular events following intensive and moderate statin therapy. J Thromb Thrombolysis. 2006, 22(1): 71-76
15. Ridker P M, Cannon C P, Morrow D, Rifai N, Rose L M, McCabe C H, Pfeffer M A, Braunwald E. the Pravastatin or Atorvastatin Evaluation and Infection Therapy Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators. C-reactive protein levels and outcomes after statin therapy. N Engl J Med, 2005, 352(1): 20-28
16. Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: An independent prognostic factor. Stroke, 2001, 32(4): 917-924
17. Muir K W, Weir C J, Alwan W, Squire I B, Lees K R. C-reactive protein and outcome after ischemic stroke. Stroke, 1999, 30(5): 981-985
18. Elkind M S, Tai W, Coates K, Paik M C, Sacco R L. High-sensitivity c-reactive protein, lipoprotein-associated phospholipase a2, and outcome after ischemic stroke. Arch Intern Med, 2006, 166(19): 2073-2080
19. Torzewski J T M, Bowyer D E, Frohlich M, Koenig W, Waltenberger J, Fitzsimmons C, Hombach V. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol, 1998, 18(9): 1386-1392
20. Zhang Y X, Cliff W J, Schoefl G I, Higgins G. Coronary c-reactive protein distribution: Its relation to development of atherosclerosis. Atherosclerosis, 1999, 145(2): 375-379
21. Chang M K, Binder C J, Torzewski M, Witztum J L. From the cover: C-reactive protein binds to both oxidized ldl and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids. PNAS, 2002, 99(20): 13043-13048
22. Pasceri V, Willerson J T, Yeh E T. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation, 2000, 102(18): 2165-2168
23. Devaraj S, Xu D Y, Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: Implications for the metabolic syndrome and atherothrombosis. Circulation, 2003, 107(3): 398-404
24. Zwaka T P, Hombach V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: Implications for atherosclerosis. Circulation, 2001, 103(9): 1194-1197
25. Venugopal S K, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that c-reactive protein decreases enos expression and bioactivity in human aortic endothelial cells. Circulation, 2002, 106(12): 1439-1441
26. Aronowski J, Hall C E. New horizons for primary intracerebral hemorrhage treatment: Experience from preclinical studies. Neurol Res, 2005, 27(3): 268-279
27. Xue M, Del Bigio M R. Immune pre-activation exacerbates hemorrhagic brain injury in immature mouse brain. J Neuroimmunol, 2005, 165(1-2): 75-82
28. Zhang X F, Attia J, D'Este C, Yu X H. Prevalence and magnitude of classical risk factors for stroke in a cohort of 5092 Chinese steelworkers over 13.5 years of follow-up. Stroke, 2004, 35(5): 1052-1056
29. Leppala J M, Virtamo J, Fogelholm R, Albanes D, Heinonen O P. Different risk factors for different stroke subtypes: Association of blood pressure, cholesterol, and antioxidants. Stroke, 1999, 30(12): 2535-2540
30. Manabe S, Okura T, Watanabe S, Higaki J. Association between carotid haemodynamics and inflammation in patients with essential hypertension. J Hum Hypertens, 2005, 19(10): 787-791
31. Garanty-Bogacka B, Syrenicz M, Syrenicz A, Gebala A, Lulka D, Walczak M. Serum markers of inflammation and endothelial activation in children with obesity-related hypertension. Neuro Endocrinol Lett, 2005, 26(3): 242-246